Inferior Alveolar Nerve Lateralization With Simultaneous Implant Placement Versus the Use of Short Dental Implants

• Sponsor: Cairo University (Other)
• Overall Status: Unknown status
• CT.gov ID: NCT03661658
• Collaborator: (none)
• Enrollment: 8
• Location: 1
• Arms: 2
• Anticipated Duration (Months): 9
• Patients Per Site Per Month: 0.9

Study Details

Study Description

Brief Summary

Assess the long term stability of short dental implants in comparison to standard implants inserted simultaneously with inferior alveolar nerve lateralization.

Condition or Disease	Intervention/Treatment	Phase
Primary Stability of the Implants; Marginal Bone Loss	Procedure: Using short dental implant; Procedure: Inferior alveolar nerve lateralization with simultaneous implant placement	N/A

Study Design

• Study Type: Interventional
• Anticipated Enrollment: 8 participants
• Allocation: Randomized
• Intervention Model: Parallel Assignment
• Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
• Primary Purpose: Treatment
• Official Title: Inferior Alveolar Nerve Lateralization With Simultaneous Implant Placement Versus the Use of Short Dental Implants
• Anticipated Study Start Date: Sep 1, 2018
• Anticipated Primary Completion Date: Feb 1, 2019
• Anticipated Study Completion Date: Jun 1, 2019

Arms and Interventions

Arm	Intervention/Treatment
Active Comparator: Inferior alveolar nerve lateralization with implant placement	Procedure: Inferior alveolar nerve lateralization with simultaneous implant placement; Inferior alveolar nerve lateralization with simultaneous implant placement in atrophic posterior mandible.
Experimental: Using short dental implant with atrophic mandible	Procedure: Using short dental implant; Using short dental implant for patients with atrophic posterior mandible.

Outcome Measures

Primary Outcome Measures

1. Primary stability [3 months]

   measuring the primary stability using the osstel

Secondary Outcome Measures

1. Marginal bone loss [3 months]

   measuring the marginal bone loss by using CBCT

Eligibility Criteria

Criteria

• Ages Eligible for Study: 20 Years to 55 Years
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: Yes

Inclusion Criteria:

• Adult patients with edentulous posterior mandible.

• Both sexes.

• No intraoral soft and hard tissue pathology.

• No systemic condition that contraindicate implant placement.

• Residual alveolar bone width longer than 6 mm height (7-9 mm).

Exclusion Criteria:

• Presence of fenestrations or dehiscence of the residual ridge.

• Heavy smokers more than 20 cigarettes per day .(24)

• Patients with systemic disease that may affect normal healing.

• Psychiatric problems

• Disorders to implant are related to history of radiation therapy to the head and neck neoplasia, or bone augmentation to implant site.

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Ehab Ahmed Shams	Cairo		Egypt

Sponsors and Collaborators

• Cairo University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Ehab Ahmed Shams, dentist-Master student, Cairo University
• ClinicalTrials.gov Identifier: NCT03661658
• Other Study ID Numbers: cairo university 8
• First Posted: Sep 7, 2018
• Last Update Posted: Sep 7, 2018
• Last Verified: Sep 1, 2018

• Individual Participant Data (IPD) Sharing Statement: Yes
• Plan to Share IPD: Yes
• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No

Study Results

No Results Posted as of Sep 7, 2018